Dimitrios C. Ziogas

3.4k total citations · 1 hit paper
99 papers, 2.2k citations indexed

About

Dimitrios C. Ziogas is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Dimitrios C. Ziogas has authored 99 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 35 papers in Molecular Biology and 26 papers in Hematology. Recurrent topics in Dimitrios C. Ziogas's work include Multiple Myeloma Research and Treatments (23 papers), Cancer Immunotherapy and Biomarkers (20 papers) and CAR-T cell therapy research (13 papers). Dimitrios C. Ziogas is often cited by papers focused on Multiple Myeloma Research and Treatments (23 papers), Cancer Immunotherapy and Biomarkers (20 papers) and CAR-T cell therapy research (13 papers). Dimitrios C. Ziogas collaborates with scholars based in Greece, United States and Italy. Dimitrios C. Ziogas's co-authors include Helen Gogas, Meletios Α. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Magdalini Migkou, Μαρία Ρούσσου, Dimitriοs Schizas and Amanda Psyrri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dimitrios C. Ziogas

94 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy for pancreatic cancer: A 2020 update

2020 308 citations Dimitrios C. Ziogas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitrios C. Ziogas Greece	26	913	755	482	301	249	99	2.2k
Dávid Ma Australia	21	1.2k 1.3×	472 0.6×	585 1.2×	293 1.0×	233 0.9×	69	2.9k
Ping Jiang China	29	1.3k 1.5×	669 0.9×	111 0.2×	493 1.6×	488 2.0×	133	3.4k
Karin Potthoff Germany	20	804 0.9×	828 1.1×	419 0.9×	397 1.3×	173 0.7×	60	2.3k
Maya Koren‐Michowitz Israel	22	791 0.9×	859 1.1×	749 1.6×	593 2.0×	224 0.9×	76	2.9k
Wataru Yamamoto Japan	20	355 0.4×	230 0.3×	308 0.6×	193 0.6×	103 0.4×	119	1.6k
Peter D. Cole United States	29	567 0.6×	408 0.5×	261 0.5×	143 0.5×	138 0.6×	135	2.6k
Gamini S. Soori United States	23	1.6k 1.8×	428 0.6×	255 0.5×	111 0.4×	332 1.3×	70	2.6k
Ming Qi United States	25	1.5k 1.7×	1.8k 2.4×	1.8k 3.7×	346 1.1×	165 0.7×	106	3.8k
Luca Fumagalli Italy	25	1.4k 1.6×	370 0.5×	160 0.3×	559 1.9×	267 1.1×	122	2.6k
Kenichiro Watanabe Japan	20	313 0.3×	428 0.6×	230 0.5×	125 0.4×	340 1.4×	134	1.5k

Countries citing papers authored by Dimitrios C. Ziogas

Since Specialization

Citations

This map shows the geographic impact of Dimitrios C. Ziogas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios C. Ziogas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios C. Ziogas more than expected).

Fields of papers citing papers by Dimitrios C. Ziogas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios C. Ziogas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios C. Ziogas. The network helps show where Dimitrios C. Ziogas may publish in the future.

Co-authorship network of co-authors of Dimitrios C. Ziogas

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios C. Ziogas. A scholar is included among the top collaborators of Dimitrios C. Ziogas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios C. Ziogas. Dimitrios C. Ziogas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ziogas, Ioannis A., et al.. (2025). HER2-targeted therapies: Unraveling their role in biliary tract cancers. Critical Reviews in Oncology/Hematology. 208. 104655–104655. 2 indexed citations

Sekulović, Lidija Kandolf, Friedegund Meier, Thomas Eigentler, et al.. (2024). LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial. Annals of Oncology. 35. S1235–S1236. 1 indexed citations

Davakis, Spyridon, et al.. (2024). Deep Learning for Image Analysis in the Diagnosis and Management of Esophageal Cancer. Cancers. 16(19). 3285–3285. 4 indexed citations

Weichenthal, Michael, Inge Marie Svane, Johanna Mangana, et al.. (2024). Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment. SHILAP Revista de lepidopterología. 2. 100271–100271. 1 indexed citations

Liontos, Michalis, Amalia Anastasopoulou, Aikaterini Gkoufa, et al.. (2024). Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition. Frontiers in Oncology. 14. 1420879–1420879. 1 indexed citations

Αγιαννιτόπουλος, Κωνσταντίνος, Georgios Tsaousis, Mustafa Özdoğan, et al.. (2023). Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.. Journal of Clinical Oncology. 41(16_suppl). e16276–e16276. 1 indexed citations

Ziogas, Dimitrios C., Eirini Papadopoulou, Helen Gogas, et al.. (2023). Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction. Cancers. 16(1). 2–2. 1 indexed citations

Anastasopoulou, Amalia, Michael Samarkos, Panagiotis Diamantopoulos, et al.. (2023). Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies. Open Forum Infectious Diseases. 10(4). ofad164–ofad164. 9 indexed citations

Ziogas, Dimitrios C., et al.. (2023). Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment. Cancers. 15(10). 2718–2718. 48 indexed citations

10.

Samarkos, Michael, et al.. (2021). Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond. Vaccines. 9(10). 1111–1111. 40 indexed citations

11.

Ziogas, Dimitrios C., Aikaterini Gkoufa, Εvangelos Cholongitas, et al.. (2020). When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report. Journal for ImmunoTherapy of Cancer. 8(2). e001322–e001322. 27 indexed citations

12.

Migkou, Magdalini, Irit Avivi, Maria Gavriatopoulou, et al.. (2020). Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma. Annals of Hematology. 99(6). 1251–1255. 14 indexed citations

13.

Gkoufa, Aikaterini, Helen Gogas, Panagiotis Diamantopoulos, Dimitrios C. Ziogas, & Mina Psichοgiou. (2020). Encephalitis in a Patient With Melanoma Treated With Immune Checkpoint Inhibitors: Case Presentation and Review of the Literature. Journal of Immunotherapy. 43(7). 224–229. 6 indexed citations

14.

Trakada, Georgia, Efstathios Kastritis, Maria Gavriatopoulou, et al.. (2019). Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome. Annals of Hematology. 98(6). 1427–1434. 7 indexed citations

15.

Moutafi, Myrto, Dimitrios C. Ziogas, Spyridon Michopoulos, et al.. (2019). A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options. BMC Medical Genetics. 20(1). 23–23. 11 indexed citations

16.

Kastritis, Efstathios, Maria Gavriatopoulou, Μαρία Ρούσσου, et al.. (2017). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy. American Journal of Hematology. 92(7). 632–639. 45 indexed citations

17.

Ζιντζαράς, Ηλίας, et al.. (2012). The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates. BMC Musculoskeletal Disorders. 13(1). 113–113. 10 indexed citations

18.

Ziogas, Dimitrios C., Michael Voulgarelis, & Ηλίας Ζιντζαράς. (2011). A Network Meta-analysis of Randomized Controlled Trials of Induction Treatments in Acute Myeloid Leukemia in the Elderly. Clinical Therapeutics. 33(3). 254–279. 26 indexed citations

19.

Papandreou, Christos N., Chrysoula Doxani, Panagiotis J. Vlachostergios, et al.. (2011). Evidence of Association Between Methylenetetrahydrofolate Reductase Gene and Susceptibility to Breast Cancer: A Candidate-Gene Association Study in a South-Eastern European Population. DNA and Cell Biology. 31(2). 193–198. 22 indexed citations

20.

Cremonini, Filippo, Dimitrios C. Ziogas, E. Kokkotou, et al.. (2010). Meta‐analysis: the effects of placebo treatment on gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 32(1). 29–42. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact